GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Star Combo Pharma Ltd (ASX:S66) » Definitions » YoY EBITDA Growth

Star Combo Pharma (ASX:S66) YoY EBITDA Growth : 33.33% (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Star Combo Pharma YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Star Combo Pharma's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 33.33%.

Star Combo Pharma's EBITDA per Share for the six months ended in Dec. 2024 was A$0.00.

Star Combo Pharma YoY EBITDA Growth Historical Data

The historical data trend for Star Combo Pharma's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Combo Pharma YoY EBITDA Growth Chart

Star Combo Pharma Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
YoY EBITDA Growth
Get a 7-Day Free Trial 118.18 -1,275.00 97.87 -1,800.00 210.53

Star Combo Pharma Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,650.00 700.00 109.68 50.00 33.33

Star Combo Pharma YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Star Combo Pharma's YoY EBITDA Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (A: Jun. 2024 )
=(EBITDA per Share (A: Jun. 2024 )-EBITDA per Share (A: Jun. 2023 ))/ | EBITDA per Share (A: Jun. 2023 ) |
=(0.021--0.019)/ | -0.019 |
=210.53 %

Star Combo Pharma's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(0.004-0.003)/ | 0.003 |
=33.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Star Combo Pharma YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Star Combo Pharma's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Star Combo Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Star Combo Pharma Ltd (ASX:S66) » Definitions » YoY EBITDA Growth
Comparable Companies
ASX:PTL ASX:ZNO ASX:SKN ASX:MCP PG XPAR:OR LSE:ULVR CL BOM:500696 KVUE KMB LSE:RKT XTER:HEN3 XTER:BEI CHD EL TSE:4452 OSTO:ESSITY B CLX TSE:8113
Traded in Other Exchanges
N/A
Address
171 - 177 Woodpark Road, Smithfield, Sydney, NSW, AUS, 2164
Website
https://www.starcombo.com.au
Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as face masks, moisturizing creams, serums, concentrates, and oils. Star Combo Pharma markets its products. It operates in two segments. Star Combo segment engages in the development, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment has made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers; and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.

Star Combo Pharma Headlines

No Headlines